article thumbnail

AbbVie Exploits Offshore Subsidiaries to Avoid Paying Taxes

World of DTC Marketing

prescription drug sales signals that big pharma will do anything to avoid hurting profits. It is unacceptable that this Republican-led giveaway has only created more loopholes for big pharma to shift profits offshore. Since AbbVie began to sell Humira in 2003, the price of Humira has been raised 27 times.

Sales 269
article thumbnail

Ten Ways to Think Differently About Small-to-Mid-Sized Pharma Launches

Eversana Intouch

Back in 2003, drugs from large pharma companies made up 36% of the late-stage R&D pipeline. These data are astonishing, given the perception that Big Pharma is the main driver of biopharma innovation. Yet, we know small-to-mid-sized pharma launches face a unique set of challenges.

Pharma 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

With new study results, Johnson & Johnson can tout Tremfya's efficacy across all skin tones

Fierce Pharma

The first biologic to win approval to treat moderate to severe psoriasis was Astellas’ now-discontinued Amevive (alefacept) in 2003, paving the way for significant progress in the disease space. | The VISIBLE trial is the first large-scale psoriasis study in only people of color, J&J said.

162
162
article thumbnail

470% price increases

World of DTC Marketing

Today, AbbVie charges approximately $77,000 for a year’s supply of Humira—470% more than when the drug was launched in 2003. Record Corporate Revenue Driven by Price Increases: Since 2003, AbbVie has collected over $107 billion in U.S. The graph below shows AbbVie’s and Amgen’s pricing for Humira and Enbrel from 2003 to 2021.

article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part i)

pharmaphorum

The present moment within and without healthcare, biotech, and pharma is a difficult and pivotal time in history, a time in which such issues need must be addressed. In September, the EU launched its recommendations on cancer screening, updated for the first time since 2003. For, services need to follow the advances of science.

article thumbnail

How VMS BioMarketing Accelerated Digital Transformation with Silverline

Silver Line CRM

Our custom system was built in 2003,” said Brochhagen. Like any small company with continued growth, VMS started with an in-house, custom developed CRM tool and later looked at utilizing a packaged CRM solution to meet their clients’ and business needs.

article thumbnail

Direct to Patient Healthcare

Healthcare Success

Yeah, for some folks, and you know, and I think my, you know, my role was, I started at Mayo clinic in public affairs on the media relations team in 2000, and then 2003 became manager of the media relations team, and then 2005 heard about this new thing called podcasting at the time which had been invented a year before. It was scary.